Magda Tsolaki*, Antonios Frontistis, Paschalis Devranis, Maria Zilakaki, Iordanis Saoulidis, Vasileios Siokas, Ioannis Papagiannis, Eleni Liouta, Evagelos Papatolis, Evripidis Pityrigkas, Vasiliki Poulidou, Evangelia Chartampila, Sofia Pettemeridou, Hadar Halivni, Cindy Cheng, Thomas Tegos
Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Makedonia, Greece
*Corresponding Author: Magda Tsolaki, Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Makedonia, Greece.
Received: September 28, 2020; Published: October 22, 2020
The potential involvement of SARS-CoV-2 in Central Nervous System (CNS) has attracted considerable attention because of the neurological and psychiatric manifestations presented throughout the disease process. There have been many reports of extra respiratory manifestations, such as neurological and psychiatric symptoms at the admission of the patients in the Hospitals, during and after SARS-CoV-2 infection. The seriousness of the virus in various parts of the body will determine what comes after the initial phase. The main brain symptoms and brain disorders that are described in many studies at admission during and after infection are: impaired memory (34,1%), dizziness (7,9 - 16,8%), headache (3,7 - 90,5%), stroke (2,8 - 8,1%) (cerebral infarction (1,6%), venous thrombosis, intracerebral, or subarachnoid hemorrhage), meningitis/encephalitis, and acute necrotizing hemorrhagic encephalopathy, impaired consciousness (7,5 - 7,8%), seizures (1-1,5%), loss of sense of smell (hyposmia (14,5% - 35,6%---34%)) or taste (hypogeusia (12,5%---34%), depressive symptoms (35%), depression (47,1% - 14,9), suicidality (2%), delirium/confusion (27,0%-27,9%), insomnia (41,9%---12,1%---100%), anxiety (35,7%---14,8%), somatization (45,9%), psychosis (3,9---4,4), and post-traumatic stress disorder (96,2% - 32,2%). Unfortunately, all these percentages are changing every day and perhaps we’ll have the reliable numbers at the end of the COVID-19 pandemic, which we wish to be very soon.
Keywords: Covid 19; Brain Disorders; Neurological and Psychiatric
Citation: Magda Tsolaki., et al. “Brain Disorders at Admission, During and After SARS-CoV-2 Infection". Acta Scientific Neurology 4.2 (2021): 37-50.
Copyright: © 2020 Magda Tsolaki., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.